SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD

Shandong Jincheng Pharmaceutical Group Co., Ltd

300233

CNE100001500

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 07/05/2024 BST			5-day change	1st Jan Change
19.29 ^CNY	+1.26%		+2.50%	+15.79%

04-24	Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-29	Shandong Jincheng Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2023, Payable on May 8, 2024	CI

Shandong Jincheng Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for 2022

March 31, 2023 at 08:39 pm

Shandong Jincheng Pharmaceutical Group Co. Ltd. proposed final cash dividend of CNY 1.500000000 per ten shares for 2022.

Latest news about Shandong Jincheng Pharmaceutical Group Co., Ltd

Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2023, Payable on May 8, 2024	03-28	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Tranche Update on Shandong Jincheng Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on February 2, 2024.	02-08	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd's Equity Buyback announced on February 2, 2024, has closed with 4,543,000 shares, representing 1.18% for CNY 55 million.	02-07	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 70 million worth of its shares.	02-02	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.	02-01	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23	CI
Jincheng Pharmaceutical Gets License to Produce E-Cigarette Nicotine	17/07/23	MT
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Approves Directorate Appointments	24/04/23	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Approves Cash Dividend for the Year 2022	24/04/23	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for 2022	31/03/23	CI
Three Jincheng Pharmaceutical Medicines Shortlisted For China’s Drug Procurement Program	30/03/23	MT
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
Jincheng Pharma Secures China's First License to Produce E-Cigarettes; Shares Slide 5%	15/06/22	MT
Shandong Jincheng Pharmaceutical Group Co., Ltd Announces Final Profit Distribution Plan for 2021, Payable on May 11, 2022	28/04/22	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Approves Profit Distribution for the Year 2021	19/04/22	CI
Shandong Jincheng Pharma Maintains Final Dividend After Swinging to Profit in 2021	28/03/22	MT
Shandong Jincheng Pharmaceutical Group Co., Ltd Announces the Profit Distribution Proposal for the Year 2021	25/03/22	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	24/03/22	CI
Shandong Jincheng Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI

Chart Shandong Jincheng Pharmaceutical Group Co., Ltd

Duration

Period

Chart Shandong Jincheng Pharmaceutical Group Co., Ltd

More charts

Shandong Jincheng Pharmaceutical Group Co., Ltd., formerly Shandong Jincheng Pharmaceutical Co., Ltd., is a China-based company principally engaged in the research, development, production and sale of cephems medicine intermediates. The Company mainly provides active ester side chain of cephalosporin products, other pharmaceutical chemical products, as well as bio-pharmaceuticals and specialty active pharmaceutical ingredient (API). The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD	+15.79%	1.01B
ELI LILLY AND COMPANY	+32.95%	698B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.97%	358B
MERCK & CO., INC.	+18.83%	328B
ABBVIE INC.	+3.54%	283B
ASTRAZENECA PLC	+15.70%	238B
NOVARTIS AG	+6.68%	203B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+6.70%	165B

Other Pharmaceuticals